My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Snowman Logistics slides after reverse turnaround in Q2
Nov 10,2016

The result was announced after market hours yesterday, 9 November 2016.

Meanwhile, the S&P BSE Sensex was up 382.88 points or 1.4% at 27,635.41.

On BSE, so far 1.44 lakh shares were traded in the counter as against average daily volume of 2.61 lakh shares in the past two weeks. The stock hit a high of Rs 58.95 and a low of Rs 57 so far during the day. The stock had hit a record low of Rs 46.20 on 29 February 2016. The stock had hit a 52-week high of Rs 97.50 on 27 November 2015. The stock had underperformed the market over the past one month till 9 November 2016, sliding 7.6% compared with 2.88% fall in the Sensex. The scrip had also underperformed the market in past one quarter, declining 18.62% as against Sensexs 2.96% fall.

The small-cap company has equity capital of Rs 167.09 crore. Face value per share is Rs 10.

Snowman Logistics net sales declined 15.06% to Rs 47.40 crore in Q2 September 2016 over Q2 September 2015.

A significant reason for the losses reported during Q2 September 2016 was that the company decided to make a one time provision of Rs 8.79 crore towards asset refurbishment both on old transport fleet and some old warehouses, as well as customer claims due to stock losses and damages at some of its warehouses. Snowman Logistics said it has taken appropriate corrective action, in terms of improvements in the systems and process to prevent any recurrence of such incidents.

Snowman Logistics is an integrated temperature controlled logistics services provider with an ability to service customers on a pan India basis.

Powered by Capital Market - Live News

Bosch rides higher on the back of stellar Q2 show
Nov 10,2016

The result was announced after market hours yesterday, 9 November 2016.

Meanwhile, the S&P BSE Sensex was up 308.44 points or 1.13% at 27,560.97.

On BSE, so far 452 shares were traded in the counter as against average daily volume of 1,776 shares in the past one quarter. The stock hit a high of Rs 22,310 and a low of Rs 21,685 so far during the day. The stock had hit a 52-week high of Rs 25,649.95 on 10 August 2016. The stock had hit a 52-week low of Rs 15,752.65 on 12 February 2016. The stock underperformed the market over the past one month till 9 November 2016, dropping 7.96% compared with the Sensexs 2.88% fall. The scrip also underperformed the market in past one quarter, declining 15.93% as against the Sensexs 2.96% decline.

The large-cap company has equity capital of Rs 31.40 crore. Face value per share is Rs 10.

Bosch announced that the board of directors yesterday, 9 November 2016, approved with effect from 1 January 2017, resignation of Dr. Steffen Berns, Managing Director consequent to assuming new position in Robert Bosch, Germany. The board redesignated Soumitra Bhattacharya, Joint Managing Director as Managing Director of the company from 1 January 2017 to 20 June 2020.

In India, Bosch is a leading supplier of technology and services in the areas of mobility solutions, industrial technology, consumer goods, and energy and building technology. Bosch is the flagship company of the Bosch Group in India. Robert Bosch GMBH holds 70.49% stake in the firm as on 28 October 2016.

Powered by Capital Market - Live News

PGCIL inches up after strong Q2 results
Nov 10,2016

The result was announced after market hours yesterday, 9 November 2016.

Meanwhile, the S&P BSE Sensex was up 322.49 points or 1.18% at 27,575.02.

On BSE, so far 82,000 shares were traded in the counter as against average daily volume of 2.13 lakh shares in the past two weeks. The stock hit a high of Rs 184.70 and a low of Rs 181.25 so far during the day. The stock had hit a record high of Rs 187.70 on 6 September 2016. The stock had hit a 52-week low of Rs 126.70 on 9 November 2015. The stock had outperformed the market over the past one month till 9 November 2016, gaining 1.95% compared with 2.88% fall in the Sensex. The scrip had also outperformed the market in past one quarter, advancing 2.56% as against Sensexs 2.96% fall.

The large-cap company has equity capital of Rs 5231.59 crore. Face value per share is Rs 10.

Power Grid Corporation of India is a state run electric power transmission utility company. The Government of India holds 57.9% stake in the firm as at 30 September 2016.

Powered by Capital Market - Live News

Cipla shrugs off weak Q2 outcome
Nov 10,2016

The result was announced after market hours yesterday, 9 November 2016.

Meanwhile, the S&P BSE Sensex was up 309.64 points or 1.14% at 27,562.17.

On BSE, so far 66,000 shares were traded in the counter as against average daily volume of 1.99 lakh shares in the past one quarter. The stock hit a high of Rs 554.30 and a low of Rs 538 so far during the day.

The large-cap company has equity capital of Rs 160.84 crore. Face value per share is Rs 2.

Cipla said that consolidated net profit dropped 34.75% to Rs 354.34 crore on 8.39% rise in total income to Rs 3778.25 crore in Q2 September 2016 over Q2 September 2015. The company said the results are not strictly comparable to Q2 September 2015 results. The Q2 September 2016 earnings include revenue from InvaGen Pharmaceuticals, a US-based company that Cipla acquired in February this year, and as Q2 September 2015 results included profit from Esomeprazole.

Cipla said that Q2 September 2016 reflected improved profitability in base business driven by better product and geography mix. The company launched 6 new products during this quarter in the US market and continues to invest in building a niche and differentiated product portfolio, Cipla said. Commenting on the results, Umang Vohra, MD and Global CEO, Cipla said that the company continues to stay focused on building operational efficiencies and strengthening presence in priority markets.

Cipla is a global pharmaceutical company

Powered by Capital Market - Live News

Bhel drops on profit booking
Nov 09,2016

Meanwhile, the S&P BSE Sensex was down 308.56 points or 1.12% at 27,282.58.

On BSE, so far 16.03 lakh shares were traded in the counter as against average daily volume of 10.23 lakh shares in the past one quarter. The stock hit a high of Rs 140.40 and a low of Rs 129 so far during the day. The stock had hit a 52-week high of Rs 190 on 9 November 2015. The stock had hit a 52-week low of Rs 90.40 on 29 February 2016. The stock had outperformed the market over the past one month till 8 November 2016, gaining 5.61% compared with 1.67% fall in the Sensex. The scrip had also outperformed the market in past one quarter, advancing 2.18% as against Sensexs 2.1% fall.

The large-cap company has equity capital of Rs 489.52 crore. Face value per share is Rs 2.

Shares of Bharat Heavy Electricals (Bhel) had risen 6.11% in the preceding two trading sessions to settle at Rs 143.15 yesterday, 8 November 2016, from its close of Rs 134.90 on 4 November 2016.

Bhel reported net profit of Rs 109 crore in Q2 September 2016 compared with net loss of Rs 180.78 crore in Q2 September 2015. Net sales rose 12.1% to Rs 6550.77 crore in Q2 September 2016 over Q2 September 2015. Order backlog stood at Rs 1.03 lakh crore as on 30 September 2016. The result was announced during trading hours yesterday, 8 November 2016. The stock had settled 2.87% higher at Rs 143.15 on that day.

State-run Bharat Heavy Electricals (Bhel) is an integrated power plant equipment manufacturer. It is one of the largest engineering and manufacturing companies in India engaged in the design, engineering, manufacture, construction, testing, commissioning and servicing of a wide range of products and services for core sectors of the economy, viz. power, transmission, industry, railways, renewable energy, oil & gas, water and defence. The Government of India currently holds 63.06% stake in Bhel (as per the shareholding pattern as on 30 September 2016).

Powered by Capital Market - Live News

Lupin extends gains post robust Q2 outcome
Nov 09,2016

The result was announced during market hours today, 9 November 2016.

Meanwhile, the S&P BSE Sensex was down 371.28 points or 1.35% at 27,219.86.

High volumes were witnessed on the counter. On BSE, so far 3.63 lakh shares were traded in the counter as against average daily volume of 1.17 lakh shares in the past one quarter. The stock hit a high of Rs 1,563.10 and a low of Rs 1,383.50, so far during the day. The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016. The stock had hit a 52-week low of Rs 1,294.05 on 29 March 2016. The stock outperformed the market over the past one month till 8 November 2016, gaining 0.7% compared with 1.67% fall in the Sensex. The scrip however underperformed the market in past one quarter, dropping 10.84% as against Sensexs 2.1% fall.

The large-cap company has equity capital of Rs 90.25 crore. Face value per share is Rs 2.

Commenting on the results, Nilesh Gupta, Managing Director, Lupin said that the company continues to invest ahead of the curve be it research or manufacturing. The Q2 September 2016 profit was impacted on account of higher research spend and forex, he added. Investment in research for the quarter was 13.6% of sales at Rs 571.60 crore.

Lupin is a pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective and NSAID space and holds global leadership position in the anti-TB segment.

Powered by Capital Market - Live News

NCC tanks on weak Q2 results
Nov 09,2016

The result was announced during market hours today, 9 November 2016.

Meanwhile, the S&P BSE Sensex was down 394.74 points or 1.43% at 27,196.40.

On BSE, so far 16.45 lakh shares were traded in the counter as against average daily volume of 9.31 lakh shares in the past one quarter. The stock hit a high of Rs 80.80 and a low of Rs 71.20 so far during the day. The stock had hit a 52-week low of Rs 55.80 on 12 February 2016. The stock had hit a 52-week high of Rs 95.65 on 26 October 2016. The stock had outperformed the market over the past one month till 8 November 2016, sliding 0.69% compared with 1.67% fall in the Sensex. The scrip had also outperformed the market in past one quarter, advancing 9.21% as against Sensexs 2.1% fall.

The mid-cap company has equity capital of Rs 111.19 crore. Face value per share is Rs 2.

NCC is a construction company. The group undertakes civil and structural infrastructure projects, real estate development and light engineering projects.

Powered by Capital Market - Live News

Lupin advances after reporting robust Q2 results
Nov 09,2016

The result was announced during market hours today, 9 November 2016.

Meanwhile, the S&P BSE Sensex was down 239.89 points or 0.87% at 27,351.25.

High volumes were witnessed on the counter. On BSE, so far 3.51 lakh shares were traded in the counter as against average daily volume of 1.17 lakh shares in the past one quarter. The stock hit a high of Rs 1,563.10 and a low of Rs 1,383.50 so far during the day. The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016. The stock had hit a 52-week low of Rs 1,294.05 on 29 March 2016. The stock outperformed the market over the past one month till 8 November 2016, gaining 0.7% compared with 1.67% fall in the Sensex. The scrip however underperformed the market in past one quarter, dropping 10.84% as against Sensexs 2.1% fall.

The large-cap company has equity capital of Rs 90.25 crore. Face value per share is Rs 2.

Lupin is a pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective and NSAID space and holds global leadership position in the anti-TB segment.

Powered by Capital Market - Live News

Oil E&P stocks decline as crude oil prices edge lower
Nov 09,2016

Meanwhile, the S&P BSE Sensex was down 358.77 points or 1.3% at 27,232.37.

Reliance Industries (RIL) (down 0.26%), Cairn India (down 2.37%), ONGC (down 1.61%) and Oil India (down 1.32%) declined. Lower crude oil prices would result in decrease in realizations from crude sales for oil exploration firms.

In global commodities markets, Brent crude oil futures edged lower as Donald Trump stunned the world by winning the US presidential election, throwing global markets into turmoil in a result reminiscent of Junes Brexit vote. Brent for January settlement was off 56 cents at $45.48 a barrel. The contract had dropped 11 cents or 0.23% to settle at $46.04 a barrel during previous trading session.

Powered by Capital Market - Live News

Sun Pharma recovers from 52-week low
Nov 09,2016

Meanwhile, the S&P BSE Sensex was down 358.31 points or 1.3% at 27,232.83.

On BSE, so far 11.83 lakh shares were traded in the counter as against average daily volume of 3.31 lakh shares in the past one quarter. The stock hit a low of Rs 572.40 so far during the day, which is a 52-week low for the counter. The stock hit a high of Rs 668.80 so far during the day. The stock had hit a 52-week high of Rs 898 on 23 February 2016. The stock had underperformed the market over the past one month till 8 November 2016, sliding 15.44% compared with 1.67% fall in the Sensex. The scrip had also underperformed the market in past one quarter, declining 23.73% as against Sensexs 2.1% fall.

The large-cap company has equity capital of Rs 240.68 crore. Face value per share is Rs 1.

Taro Pharmaceutical Industries (Taro Pharma) net profit fell 7.2% to $123.7 million on 7.9% growth in net sales to $228.8 million in Q2 September 2016 over Q2 September 2015. The top line during the quarter was driven by increased volumes in the US generic business. However, the increase in operating profit was offset by the decrease in foreign exchange income and an increase in tax expense thereby pulling down the bottom line in Q2 September 2016.

Sun Pharmaceutical Industries (Sun Pharma) is set to announce Q2 September 2016 results tomorrow, 10 November 2016. The companys consolidated net profit surged 265.8% to Rs 2033.71 crore on 22.7% growth in net sales to Rs 8006.68 crore in Q1 June 2016 over Q1 June 2015.

Sun Pharmaceutical Industries is the worlds fifth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Bank stocks drop after govt bans some bank notes to curb black money
Nov 09,2016

Among private sector banks, IndusInd Bank (down 1.66%), Axis Bank (down 0.66%), ICICI Bank (down 2.1%), Kotak Mahindra Bank (down 0.81%), Yes Bank (down 1.43%), and HDFC Bank (down 0.53%) declined.

Among public sector bank stocks, Canara Bank (down 0.22%), Union Bank of India (down 1.44%), Bank of India (down 0.73%), and Bank of Baroda (down 0.65%) declined. State Bank of India (SBI) (up 1.86%) and Punjab National Bank (up 0.25%) gained.

The S&P BSE Bankex shed 167.70 points or 0.75% at 22,166.87. It outperformed the Sensex which was down 383.12 points or 1.39% at 27,208.02.

The S&P BSE Bankex outperformed the market over the past one month till 8 November 2016, gaining 0.82% compared with 1.67% fall in the Sensex. The index also outperformed the market in past one quarter, gaining 3.13% as against Sensexs 2.1% fall.

With a view to curb financing of terrorism through the proceeds of fake Indian currency notes (FICN) and use of such funds for subversive activities such as espionage, smuggling of arms, drugs and other contrabands into India, and for eliminating black money which casts a long shadow of parallel economy on real economy, it has been decided by the NDA government yesterday, 8 November 2016, to cancel the legal tender character of the high denomination bank notes of Rs 500 and Rs 1,000 denominations issued by the Reserve Bank of India (RBI) till now. This takes effect from the expiry of the 8 November 2016.

Fake Indian currency notes (FICN) in circulation in these denominations are comparatively larger as compared to those in other denominations. For a common person, the fake notes look similar to genuine notes. Use of FICN facilitates financing of terrorism and drug trafficking. Use of high denomination notes for storage of unaccounted wealth has been evident from cash recoveries made by law enforcement agencies from time to time. High denomination notes are known to facilitate generation of black money. New Series bank notes of Rs 500 and Rs 2,000 denominations will be introduced for circulation from 10 November 2016. Infusion of Rs 2,000 bank notes will be monitored and regulated by RBI. Introduction of new series of banknotes which will be distinctly different from the current ones in terms of look, design, size and colour has been planned.

The World Bank in July, 2010 estimated the size of the shadow economy for India at 20.7% of the GDP in 1999 and rising to 23.2% in 2007. There are similar estimates made by other Indian and international agencies. A parallel shadow economy corrodes and eats into the vitals of the countrys economy. It generates inflation which adversely affects the poor and the middle classes more than others. It deprives Government of its legitimate revenues which could have been otherwise used for welfare and development activities.

Keeping in view the need to minimise inconvenience to the public, the operational guidelines have been issued which among others includes deposition of old high denomination bank notes by individuals/persons into their bank accounts and/or exchanged in bank branches or Issue offices of RBI till the close of business hours on 30 December 2016. Old high denomination bank notes of aggregate value of Rs 4,000 only or below held by a person can be exchanged by him/her at any bank branch or Issue Office of Reserve Bank of India for any denomination of bank notes having legal tender character, provided a Requisition Slip as per format to be specified by RBI is presented with proof of identity and along with the Old High Denomination Bank Notes. Similar facilities will also be made available in Post Offices.

Cash withdrawal from a bank account, over the counter will be restricted to Rs 10,000 subject to an overall limit of Rs 20,000 in a week for the first fortnight, i.e., until the end of business hours on 24 November 2016. There will be no restriction on the use of any non-cash method of operating the account which will include cheques, demand drafts, credit/debit cards, mobile wallets and electronic fund transfer mechanisms. Withdrawal from ATMs would be restricted to Rs 2,000 per day per card up to 18 November 2016. The limit will be raised to Rs 4,000 per day per card from 19 November 2016 onwards.

For those who are unable to exchange their Old High Denomination Bank Notes or deposit the same in their bank accounts on or before 30 December 2016, an opportunity will be given to them to do so at specified offices of the RBI on later dates along with necessary documentation as may be specified by the Reserve Bank of India. Instruction is also being issued for closure of banks and Government Treasuries on 9 November, 2016. The bank branches and Government Treasuries will function from 10 November, 2016.

Powered by Capital Market - Live News

Volumes jump at Greenlam Industries counter
Nov 09,2016

Greenlam Industries clocked volume of 1.20 lakh shares by 13:35 IST on BSE, a 1519.87-times surge over two-week average daily volume of 79 shares. The stock lost 1.03% at Rs 700.

Repco Home Finance notched up volume of 2.59 lakh shares, a 88.45-fold surge over two-week average daily volume of 3,000 shares. The stock tumbled 6.59% at Rs 674.65.

Vesuvius India saw volume of 57,000 shares, a 57.76-fold surge over two-week average daily volume of 1,000 shares. The stock fell 2.4% at Rs 1,145.

United Breweries clocked volume of 8.31 lakh shares, a 40.14-fold surge over two-week average daily volume of 21,000 shares. The stock rose 0.54% at Rs 907.35.

Oberoi Realty saw volume of 9.85 lakh shares, a 33.88-fold rise over two-week average daily volume of 29,000 shares. The stock lost 10.23% at Rs 303.50.

Powered by Capital Market - Live News

Bombay Burmah slides as net loss widens in Q2
Nov 09,2016

The result was announced after market hours yesterday, 8 November 2016.

Meanwhile, the S&P BSE Sensex was down 755.39 points or 2.74% at 26,835.75.

On BSE, so far 29,000 shares were traded in the counter as against average daily volume of 70,827 shares in the past one quarter. The stock hit a high of Rs 542.90 and a low of Rs 494.55 so far during the day. The stock had hit a 52-week low of Rs 311 on 12 February 2016. The stock had hit a record high of Rs 673.40 on 5 October 2016. The stock had underperformed the market over the past one month till 8 November 2016, sliding 13.88% compared with 1.67% fall in the Sensex. The scrip had, however, outperformed the market in past one quarter, advancing 15.2% as against Sensexs 2.1% fall.

The mid-cap company has equity capital of Rs 13.95 crore. Face value per share is Rs 2.

Bombay Burmah Trading Corporations net sales rose 10.4% to Rs 66.75 crore in Q2 September 2016 over Q2 September 2015.

Bombay Burmah Trading Corporation has diversified its interests into tea, coffee, other plantation products, biscuit and dairy products, auto electric and white goods parts, weighing products, horticulture and landscaping services, healthcare products (viz.) dental, orthopaedic and opthalmic products.

Powered by Capital Market - Live News

IT stocks drop as Donald Trump slated to win US presidential elections
Nov 09,2016

Meanwhile, the S&P BSE Sensex was down 947.46 points or 3.43% at 26,643.68.

HCL Technologies (down 2.39%), TCS (down 5.17%), Infosys (down 3.24%), Tech Mahindra (down 4.6%) and Wipro (down 2.41%) edged lower.

The BSE IT index underperformed the market over the past one month till 8 November 2016, falling 2.33% compared with the Sensexs 1.67% fall. The index also underperformed the market in past one quarter, dropping 10.35% as against the Sensexs 2.1% decline.

So far, Trump won 264 votes and Hillary won 215 votes in a 270 Electoral College votes needed to win the White House. Trump is known to be in favour of protectionist measures, such as stricter visa norms to curtail jobs for Indian and other non-US employees. Trump has made outsourcing and liberal immigration laws a major campaign issue in this election in an effort to protect American jobs. IT firms profit margins are expected to come under pressure if Trump tightens immigration laws and take harsh measures to discourage outsourcing.

US is the biggest outsourcing market for the Indian IT firms.

Powered by Capital Market - Live News

Hinduja Foundries slumps after dismal Q2 numbers
Nov 09,2016

The result was announced during market hours today, 9 November 2016.

Meanwhile, the S&P BSE Sensex was down 864.98 points or 3.13% at 26,726.16.

On BSE, so far 4,735 shares were traded in the counter as against average daily volume of 15,177 shares in the past one quarter. The stock hit a high of Rs 35 and a low of Rs 30 so far during the day. The stock had hit a 52-week low of Rs 27.30 on 12 February 2016. The stock had hit a 52-week high of Rs 65 on 7 July 2016. The stock had outperformed the market over the past one month till 8 November 2016, sliding 1.41% compared with 1.67% fall in the Sensex. The scrip had, however, underperformed the market in past one quarter, declining 36.39% as against Sensexs 2.1% fall.

The small-cap company has equity capital of Rs 207.05 crore. Face value per share is Rs 10.

Hinduja Foundries total income from operations declined 1.07% to Rs 155.57 crore in Q2 September 2016 over Q2 September 2015.

Hinduja Foundries is one of the Indias leading foundry group with the capacity to produce cylinder block and head ranging from 25 kilograms (kgs) to 500 kgs. From castings for automobiles and tractors to industrial engines, construction equipment and power generation equipment, Hinduja Foundries meets the stringent requirement of diverse segments. It even caters to the exceptionally high standards of defence applications.

Powered by Capital Market - Live News